Prof Sebastien Gouy is an expert in Oncology at Institut Gustave Roussy (France). As of September 2026, ScienceLeadR ranks Sebastien Gouy in the top 1% of experts worldwide for Uterine Diseases, Urogenital Neoplasms and Genital Neoplasms, Female. Sebastien Gouy has authored 341 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 848 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Sebastien Gouy Institut Gustave Roussy France
848 ScienceLeadR Reputation 848
Network Map

Oncology

Subspecialties: Gynecology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Institut Gustave Roussy

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 341

Citations

Citations: 7 355 1st author: 29 Last author: 42 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Lymphangiography and lymphatic embolization for post-surgical abdominal leaks.
PMID 42742713 — lymphocele, safety, diagnostic imaging, chylous ascites, paracentesis, ascites
Abdom Radiol (NY)20260
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.
PMID 42361574 — cytoreduction surgical procedures, ovary, genital neoplasms, female, retrospective studies, ovarian neoplasms
Gynecol Oncol20260
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer database.
PMID 42013623 — cytoreduction surgical procedures, lymph nodes, ovary, neoplasms, drug therapy, lymph, ovarian neoplasms, therapeutics, dissection, prognosis, chemotherapy
Eur J Surg Oncol20260
Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 cases.
PMID 41719896 — lymph nodes, lymph node excision, uterine cervical neoplasms, genital neoplasms, female, neoplasms, renal veins, positron emission tomography computed tomography, neoplasm metastasis, lymph, veins
Gynecol Oncol20260
Fertility preservation in gynecologic oncology: evaluating knowledge, practices, and barriers among French healthcare providers.
PMID 41494211 — fertility, genital neoplasms, female, fertility preservation, cryopreservation, oocytes, health personnel, tissues, reproductive medicine
Int J Gynecol Cancer20250

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 2 2
Phase 3 2

By status:

Active not recruiting 2
Completed 2
Recruiting 1
Unknown 1

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 4

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma
Phase 3Recruiting2023

LeadR Networks

Main global connection map